Evidence map›Paper›PMID 36111417›Full record

ReviewAnnals of medicine2022

Primary care management of Long-Term opioid therapy.

Phillip O Coffin, Rebecca S Martinez, Brian Wylie, Bunny Ryder

Open access · goldAbstract readReview
In one paragraph

Review in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Phillip O CoffinSan Francisco Department of Public Health, Center on Substance Use and Health, San Francisco, CA, USA.
Rebecca S MartinezSan Francisco Department of Public Health, Center on Substance Use and Health, San Francisco, CA, USA.
Brian WylieSan Francisco Department of Public Health, Center on Substance Use and Health, San Francisco, CA, USA.
Bunny RyderSan Francisco Department of Public Health, Center on Substance Use and Health, San Francisco, CA, USA.
San Francisco Department of Public Health · US

Funding

Cohort Study of Opioids, Pain, and Safety in an era of Changing Policy (COPING)R01DA040189 · NIDA · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI COFFIN, PHILLIP O · 2016 to 2020
$2.2M
Midcareer K24 Award for Mentoring and Patient-Oriented ResearchK24DA042720 · NIDA · SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH · PI PHILLIP O COFFIN · 2016 to 2026
$1.6M
Substance use outcomes of opioid dose reduction and discontinuationU01CE002793 · CE · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI COFFIN, PHILLIP O · 2016 to 2017
$799k
NCIPC CDC HHS U01 CE002793NIDA NIH HHS K24 DA042720NIDA NIH HHS R01 DA040189
6 · The paper itself

Abstract

The United States underwent massive expansion in opioid prescribing from 1990-2010, followed by opioid stewardship initiatives and reduced prescribing. Opioids are no longer considered first-line therapy for most chronic pain conditions and clinicians should first seek alternatives in most circumstances. Patients who have been treated with opioids long-term should be managed differently, sometimes even continued on opioids due to physiologic changes wrought by long-term opioid therapy and documented risks of discontinuation. When providing long-term opioid therapy, clinicians should document opioid stewardship measures, including assessments, consents, medication reconciliation, and offering naloxone, along with the rationale to continue opioid therapy. Clinicians should screen regularly for opioid use disorder and arrange for or directly provide treatment. In particular, buprenorphine can be highly useful for co-morbid pain and opioid use disorder. Addressing other substance use disorders, as well as preventive health related to substance use, should be a priority in patients with opioid use disorder. Patient-centered practices, such as shared decision-making and attending to related facets of a patient's life that influence health outcomes, should be implemented at all points of care.Key messagesAlthough opioids are no longer considered first-line therapy for most chronic pain, management of patients already taking long-term opioid therapy must be individualised.Documentation of opioid stewardship measures can help to organise opioid prescribing and protect clinicians from regulatory scrutiny.Management of resultant opioid use disorder should include provision of medications, most often buprenorphine, and several additional screening and preventive measures.

Indexed as

BuprenorphineChronic PainOpioid-Related DisordersAnalgesics, OpioidHumansNaloxonePractice Patterns, Physicians'Primary Health CareUnited StatesAnalgesics, OpioidBuprenorphineNaloxonebuprenorphinechronic painnaloxoneOpioidsopioid stewardshipsubstance use disorder

Identifiers

PMID36111417
PMCPMC9487960
OpenAlexW4296025827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.